Skip Navigation


BJA Advance Access originally published online on April 4, 2006
British Journal of Anaesthesia 2006 96(6):722-726; doi:10.1093/bja/ael080
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/6/722    most recent
ael080v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Alhashemi, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alhashemi, J. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Dexmedetomidine vs midazolam for monitored anaesthesia care during cataract surgery

J. A. Alhashemi*

Department of Anesthesia and Critical Care, King Abdulaziz University, King Abdulaziz University Hospital PO Box 31648, Jeddah, Saudi Arabia

*E-mail: jalhashemi{at}kau.edu.sa

Background. Cataract surgery is commonly performed under local anaesthesia with midazolam sedation. Dexmedetomidine, a sedative-analgesic, is devoid of respiratory depressant effects, and its use in cataract surgery has not been reported. This double-blind study compared the use of dexmedetomidine and midazolam in patients undergoing cataract surgery.

Methods. Forty-four patients undergoing cataract surgery under peribulbar anaesthesia randomly received either i.v. dexmedetomidine 1 µg kg–1 over 10 min; followed by 0.1–0.7 µg kg–1 h–1 i.v. infusion (Group D), or midazolam 20 µg kg–1 i.v.; followed by 0.5 mg i.v. boluses as required (Group M). Sedation was titrated to a Ramsay sedation score of 3. Mean arterial pressure (MAP), heart rate (HR), readiness for recovery room discharge (time to Aldrete score of 10), and patients' and surgeons' satisfaction (on a scale of 1–7) were determined.

Results. MAP and HR were lower in Group D compared with Group M [86 (SE 3) vs 102 (3) mm Hg and 65 (2) vs 72 (2) beats min–1, respectively] (P<0.05). Group D patients had slightly higher satisfaction with sedation [median (IQR): 6 (6–7) vs 6 (5–7), P<0.05], but delayed readiness for discharge [45 (36–54) vs 21 (10–32) min, P<0.01] compared with patients in Group M. Surgeons' satisfaction was comparable in both groups [5 (4–6) vs 5 (4–6)].

Conclusion. Compared with midazolam, dexmedetomidine does not appear to be suitable for sedation in patients undergoing cataract surgery. While there was a slightly better subjective patient satisfaction, it was accompanied by relative cardiovascular depression and delayed recovery room discharge.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
H. Ayoglu, H. Altunkaya, Y. Ozer, O. Yapakci, I. Ozkocak, O. Oz, A. Alpay, and S. H. Ugurbas
Dexmedetomidine sedation during cataract surgery under regional anaesthesia
Br. J. Anaesth., September 1, 2007; 99(3): 448 - 448.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
A. T Gerlach and J. F Dasta
Dexmedetomidine: An Updated Review
Ann. Pharmacother., February 1, 2007; 41(2): 245 - 252.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.